“…When administered intrathecally, butorphanol tartrate is used as an adjuvant in combination with local anaesthetics to provide satisfactory analgesia, reduce the adverse effects of local anaesthetic drugs, and prolong the duration of postoperative analgesia [24] . Intrathecal local anaesthetics interfere with afferent and efferent sensory and motor impulse conduction by inhibiting voltage-gated sodium channels in the spinal cord, whereas intrathecal injection of butorphanol activates opioid receptors in the dorsal grey matter of the spinal cord and blocks calcium channels to regulate the function of afferent pain fibres, producing a synergistic effect when the two are used in combination, i.e., local anaesthetic drugs blocking the Na+ channels and butorphanol blocking Ca+ channels, which improves both the analgesic quality, as well as reducing sympathetic inhibition and obtaining more stable haemodynamics, which is very beneficial for cardiac patients undergoing non-cardiac surgery [25,26] . At the same time, intrathecal injection of Butorphanol combined with local anaesthetic drugs can also reduce the intensity of motor block, which is conducive to the early walking of patients, and can reduce the occurrence of itching and other complications [27] .…”